EPB127 | Platelet reactivity and activation in people living with HIV | E-poster | Other ART complications and adverse reactions |
EPB128 | Impact of differentiated service delivery models on retention and viral load suppression among ART clients in Katakwi Destrict | E-poster | Other ART complications and adverse reactions |
EPC296 | A prospective analysis of PrEP adherence and depressive symptoms among Kenyan women who initiated PrEP during pregnancy and postpartum | E-poster | Optimizing vertical transmission prevention programmes |
EPE419 | A qualitative study of patient and provider experiences with telemedicine for HIV care | E-poster | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |
EPE420 | COVID-19, telehealth and HIV care | E-poster | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |
EPE421 | Responding to the COVID-19 pandemic: HIV continuing professional development virtual seminars for healthcare workers in Ukraine | E-poster | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |
EPE422 | Training adaptations to address quality improvement in PEPFAR-supported Latin America programs in the era of COVID-19 | E-poster | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |
EPE423 | Brazilian Ministry of Health strategies to address disruptions to HIV testing during COVID-19 pandemic | E-poster | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |
EPE424 | Circumventing the impact of COVID-19 pandemic on access to HIV-1 RNA assay in Nigeria | E-poster | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |
EPE425 | Improving viral load coverage and suppression in four Central American countries during the COVID-19 pandemic | E-poster | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |